FDA Approves New Intranasal Dental Anesthetic

Posted by on Sep 30, 2016 in Blogs | 0 comments


Do you have a fear of needles? Have no fear! There’s now a form of dental anesthetic that requires no needles at all and can be administered intranasally.

On June 29, 2016, a regional nasal spray anesthetic called Kovanaze (a mix of tetracaine and oxymetazoline, a nasal decongestant) produced by St. Renatus, LLC was approved by the U.S. Food and Drug Administration. Although Kovanaze is only safe to be used during restorative procedures for patients over 88 pounds as of now, the company plans on expanding its use to children too.

While Kovanaze’s side effects include rhinorrhea, nasal congestion, and nasal discomfort, the results of a recent Phase 3 clinical trial conducted by researchers at the University of Pennsylvania School of Medicine provided evidence that the Kovanaze was safe and effective.

This development is great news for those who fear needles and can help decrease the number of accidental needle-stick injuries as well.

Feel free to contact Drs. Ali & Ali and their newest addition to the team, Dr. Zarah Ali, if you have any thoughts or concerns. The caring team at Wellesley Dental Group will be happy to answer your questions! Contact us today at 781-237-9071 or smile@wellesleydentalgroup.com to set up an appointment and consultation.

Your little ones and teens are welcome to visit our pediatric dentist Dr. VanDr. Emad is happy to help with your orthodontic needs. For wisdom teeth extractions or any other periodontal or oral surgery needs, Dr. Ghazi would be more than willing to help.




Leave a Reply

Your email address will not be published. Required fields are marked *